vs
agilon health, inc.（AGL）与KEMPER Corp（KMPR）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是KEMPER Corp的1.4倍（$1.6B vs $1.1B），KEMPER Corp净利率更高（-0.7% vs -12.0%，领先11.3%），agilon health, inc.同比增速更快（3.1% vs -4.7%），KEMPER Corp自由现金流更多（$166.2M vs $-23.5M），过去两年KEMPER Corp的营收复合增速更高（-0.5% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
坎伯公司（Kemper Corporation）是总部位于美国伊利诺伊州芝加哥的保险服务商，总资产近130亿美元，旗下品牌矩阵为个人、家庭及企业客户提供多元保险产品服务。
AGL vs KMPR — 直观对比
营收规模更大
AGL
是对方的1.4倍
$1.1B
营收增速更快
AGL
高出7.8%
-4.7%
净利率更高
KMPR
高出11.3%
-12.0%
自由现金流更多
KMPR
多$189.7M
$-23.5M
两年增速更快
KMPR
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.1B |
| 净利润 | $-188.9M | $-8.0M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | — |
| 净利率 | -12.0% | -0.7% |
| 营收同比 | 3.1% | -4.7% |
| 净利润同比 | -78.5% | -108.2% |
| 每股收益（稀释后） | — | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLKMPR
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.5B | $1.2B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
净利润AGLKMPR
| Q4 25 | $-188.9M | $-8.0M | ||
| Q3 25 | $-110.2M | $-21.0M | ||
| Q2 25 | $-104.4M | $72.6M | ||
| Q1 25 | $12.1M | $99.7M | ||
| Q4 24 | $-105.8M | $97.4M | ||
| Q3 24 | $-117.6M | $73.7M | ||
| Q2 24 | $-30.7M | $75.4M | ||
| Q1 24 | $-6.1M | $71.3M |
营业利润率AGLKMPR
| Q4 25 | -12.3% | — | ||
| Q3 25 | -9.1% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -1.4% | — | ||
| Q4 24 | -7.1% | — | ||
| Q3 24 | -9.2% | 11.2% | ||
| Q2 24 | -2.9% | 10.1% | ||
| Q1 24 | -0.4% | 7.6% |
净利率AGLKMPR
| Q4 25 | -12.0% | -0.7% | ||
| Q3 25 | -7.7% | -1.7% | ||
| Q2 25 | -7.5% | 5.9% | ||
| Q1 25 | 0.8% | 8.4% | ||
| Q4 24 | -6.9% | 8.2% | ||
| Q3 24 | -8.1% | 6.3% | ||
| Q2 24 | -2.1% | 6.7% | ||
| Q1 24 | -0.4% | 6.2% |
每股收益（稀释后）AGLKMPR
| Q4 25 | — | $-0.03 | ||
| Q3 25 | — | $-0.34 | ||
| Q2 25 | — | $1.12 | ||
| Q1 25 | — | $1.54 | ||
| Q4 24 | — | $1.51 | ||
| Q3 24 | — | $1.14 | ||
| Q2 24 | — | $1.16 | ||
| Q1 24 | — | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | — |
| 总债务越低越好 | $35.0M | $943.5M |
| 股东权益账面价值 | $126.7M | $2.7B |
| 总资产 | $1.3B | $12.5B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资AGLKMPR
| Q4 25 | $173.7M | — | ||
| Q3 25 | $171.7M | $371.2M | ||
| Q2 25 | $171.4M | $407.6M | ||
| Q1 25 | $136.9M | $545.3M | ||
| Q4 24 | $188.2M | $1.0B | ||
| Q3 24 | $148.2M | $696.9M | ||
| Q2 24 | $109.5M | $539.1M | ||
| Q1 24 | $111.7M | $520.7M |
总债务AGLKMPR
| Q4 25 | $35.0M | $943.5M | ||
| Q3 25 | — | $943.1M | ||
| Q2 25 | — | $942.6M | ||
| Q1 25 | — | $942.1M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
股东权益AGLKMPR
| Q4 25 | $126.7M | $2.7B | ||
| Q3 25 | $306.1M | $2.7B | ||
| Q2 25 | $408.9M | $370.0M | ||
| Q1 25 | $500.3M | $366.0M | ||
| Q4 24 | $471.0M | $2.8B | ||
| Q3 24 | $574.9M | $2.8B | ||
| Q2 24 | $676.6M | $358.0M | ||
| Q1 24 | $689.3M | $2.6B |
总资产AGLKMPR
| Q4 25 | $1.3B | $12.5B | ||
| Q3 25 | $1.6B | $12.4B | ||
| Q2 25 | $1.7B | $12.6B | ||
| Q1 25 | $1.9B | $12.5B | ||
| Q4 24 | $1.7B | $12.6B | ||
| Q3 24 | $2.1B | $12.6B | ||
| Q2 24 | $2.2B | $12.6B | ||
| Q1 24 | $2.3B | $12.6B |
负债/权益比AGLKMPR
| Q4 25 | 0.28× | 0.35× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 2.55× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.50× | ||
| Q2 24 | — | 3.88× | ||
| Q1 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $175.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $166.2M |
| 自由现金流率自由现金流/营收 | -1.5% | 14.7% |
| 资本支出强度资本支出/营收 | 0.2% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $553.9M |
8季度趋势，按日历期对齐
经营现金流AGLKMPR
| Q4 25 | $-20.5M | $175.0M | ||
| Q3 25 | $-18.2M | $139.9M | ||
| Q2 25 | $-35.1M | $89.6M | ||
| Q1 25 | $-32.0M | $180.0M | ||
| Q4 24 | $16.4M | $175.1M | ||
| Q3 24 | $-7.7M | $141.9M | ||
| Q2 24 | $-18.7M | $22.9M | ||
| Q1 24 | $-47.8M | $43.0M |
自由现金流AGLKMPR
| Q4 25 | $-23.5M | $166.2M | ||
| Q3 25 | $-21.3M | $133.4M | ||
| Q2 25 | $-38.3M | $82.0M | ||
| Q1 25 | $-35.8M | $172.3M | ||
| Q4 24 | $13.2M | $165.4M | ||
| Q3 24 | $-11.2M | $131.4M | ||
| Q2 24 | $-22.0M | $5.2M | ||
| Q1 24 | $-50.9M | $27.7M |
自由现金流率AGLKMPR
| Q4 25 | -1.5% | 14.7% | ||
| Q3 25 | -1.5% | 10.8% | ||
| Q2 25 | -2.7% | 6.7% | ||
| Q1 25 | -2.3% | 14.4% | ||
| Q4 24 | 0.9% | 13.9% | ||
| Q3 24 | -0.8% | 11.1% | ||
| Q2 24 | -1.5% | 0.5% | ||
| Q1 24 | -3.2% | 2.4% |
资本支出强度AGLKMPR
| Q4 25 | 0.2% | 0.8% | ||
| Q3 25 | 0.2% | 0.5% | ||
| Q2 25 | 0.2% | 0.6% | ||
| Q1 25 | 0.3% | 0.6% | ||
| Q4 24 | 0.2% | 0.8% | ||
| Q3 24 | 0.2% | 0.9% | ||
| Q2 24 | 0.2% | 1.6% | ||
| Q1 24 | 0.2% | 1.3% |
现金转化率AGLKMPR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | -2.64× | 1.81× | ||
| Q4 24 | — | 1.80× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
KMPR
| Specialty Property Casualty Insurance Segment | $995.1M | 88% |
| Life Insurance Segment1 | $140.7M | 12% |
